Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma

Background: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy with high morbidity and mortality worldwide. Tumor immune microenvironment (TIME) plays a pivotal role in the outcome and treatment of HCC. However, the effect of immune cell signatures (ICSs) representing the cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Linfeng, Jian, Xingxing, Liu, Zhenhao, Zhao, Jingjing, Zhang, Siwen, Lin, Yong, Xie, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503558/
https://www.ncbi.nlm.nih.gov/pubmed/34646307
http://dx.doi.org/10.3389/fgene.2021.741226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503558/
https://www.ncbi.nlm.nih.gov/pubmed/34646307
http://dx.doi.org/10.3389/fgene.2021.741226

Ejemplares similares